As more hospitals explore the benefits of robotic-assisted surgery, many are comparing two leading domestic options — the TINAVI “TiRobot” series and Perlove’s PL300B orthopedic surgical robot. Below is a professional comparison to help decision-makers better understand the strengths of each brand.
1. Manufacturer Strength
TINAVI Medical Technologies Co., Ltd. (founded in 2005, Beijing) is China’s first and the world’s fifth company to obtain a medical robot registration license. As a pioneer in intelligent surgical systems, TINAVI has established a strong presence in the high-end hospital segment with its advanced R&D capabilities.
Nanjing Perlove Medical Equipment Co., Ltd. (founded in 2003) is a leading manufacturer of medical imaging systems and the creator of China’s first domestically developed 3D C-arm. Perlove is also one of the national standard-setting enterprises for medical X-ray equipment, demonstrating its technical expertise and manufacturing strength.
2. System Accuracy
TINAVI’s “Tianji” series achieves a system accuracy of ≤1.5 mm, utilizing 3D spatial positioning and supporting integration with third-party imaging systems.
Perlove’s PL300B orthopedic surgical robot achieves an even higher accuracy of ≤0.7 mm, also based on 3D positioning, with all imaging components developed on a fully integrated platform. This ensures seamless data alignment and improved intraoperative precision.
3. Technical Highlights
TINAVI’s Tianji robots feature an active infrared tracking system for real-time navigation and positioning, widely used in spinal, joint, and trauma surgeries.
Perlove Medical offers a complete solution combining a spinal surgery robot with a 3D C-arm imaging system. Through its one-step automatic registration and trajectory alignment technology, Perlove enables faster setup, smoother workflow, and higher efficiency during surgery.
4. Market Positioning
TINAVI leads the high-end hospital market with its comprehensive technology portfolio and established clinical reputation.
Perlove Medical, on the other hand, focuses on affordable innovation and broad clinical adaptability, making advanced robotic-assisted surgery more accessible to regional and primary healthcare institutions.
